Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03VOM
|
|||
Former ID |
DNC007835
|
|||
Drug Name |
3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one
|
|||
Synonyms |
3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one; BAS 00130047; AC1MJHY9; beta-Aminophenylketone, 3h; CHEMBL236033; BDBM18821; ZINC3065713; NCGC00168202-01; 4'-Hexyl-beta-(dimethylamino)propiophenone
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H27NO
|
|||
Canonical SMILES |
CCCCCCC1=CC=C(C=C1)C(=O)CCN(C)C
|
|||
InChI |
1S/C17H27NO/c1-4-5-6-7-8-15-9-11-16(12-10-15)17(19)13-14-18(2)3/h9-12H,4-8,13-14H2,1-3H3
|
|||
InChIKey |
KDBREDBLOZXWHK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Thyroid hormone receptor alpha (THRA) | Target Info | Inhibitor | [1] |
Thyroid hormone receptor beta (THRB) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Thyroid hormone signaling pathway | ||||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | Endochondral Ossification | |||
Nuclear Receptors | ||||
SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. J Med Chem. 2007 Nov 1;50(22):5269-80. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.